07.10.2013
- Biogen Idec's hot-selling new multiple sclerosis drug Tecfidera remained effective for patients taking the medicine for at least four years with no new safety problems, according...
22.03.2013
- European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...
